2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Oxagen Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4 OC000459 - Healthy Volunteers | Phase 1 | Completed | Oxagen Ltd | 20 | 2010-02-01 | 2010-09-02 |
| The Effects of OC000459 on Nasal Mediators Oxagen OC000459 - Allergic Rhinitis | Phase 1 / Phase 2 | Completed | Trevor Hansel | 12 | 2023-10-30 |
(5-fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)acetic acid (1)
United Kingdom (2)